coinbase crypto currencies- Top Related searches

Institution: In the first half of 2024, the scale of China's edge cloud market increased by 21% year-on-year. Recently, the latest report "China Edge Cloud Market Tracking Research, 2024H1" released by International Data Corporation (IDC) shows that in the first half of 2024, the scale of China's edge cloud market totaled 5.48 billion yuan, with a year-on-year growth rate of 21.0%. Among them, the market scale of edge public cloud services, edge exclusive cloud services and edge cloud solutions reached RMB 3.00 billion, RMB 970 million and RMB 1.50 billion respectively. Internet audio and video distribution and real-time interaction based on edge resources, edge game clothes, cloud terminals and cloud games, cloud network services, and lightweight IT architecture migration of local industry customers are the core driving forces for market growth in this period.The three departments issued the tax policy on the transformation of operating cultural institutions into enterprises in the cultural system reform, and the Ministry of Finance, the State Administration of Taxation and the Central Propaganda Department issued the Announcement on the Tax Policy on the Transformation of Operating Cultural Institutions into Enterprises in the Cultural System Reform, which mentioned that operating cultural institutions can enjoy the following transitional tax preferential policies: if operating cultural institutions are transformed into enterprises before December 31, 2022, they will be exempted from enterprise income tax from the date of registration of transformation to December 31, 2027. If a cultural unit funded by the financial department is transformed into an enterprise before December 31, 2022, its self-use property will be exempted from property tax from the date of registration of transformation to December 31, 2027.Sony group's share price hit a record high in intraday trading.

Musk praised Tesla China. According to the data, Tesla sold 21,900 vehicles in China last week (12.2-12.8), which was the second best week of Tesla in 2024 so far. The excellent sales performance in China market was highly recognized by Tesla CEO Musk, who praised "the excellent work of Tesla China" online on social media.China Minerals and Guangxi Iron and Steel have established mining technology companies. The enterprise search APP shows that recently, China National Mining Chain (Guangxi) Mining Technology Co., Ltd. was established, with Ji Wendong as the legal representative and a registered capital of 90 million yuan. Its business scope includes mineral washing and processing, metal ore sales and metal material sales. Enterprise survey shows that the company is jointly owned by China Mineral's China Mineral Resources Group International Supply Chain Co., Ltd. and Guangxi Iron and Steel Group Co., Ltd.I SQUARED CAPITAL is reported to have started due diligence on Hong Kong Broadband.

The Israeli army attacked a house in the northern Gaza, killing 18 people. The reporter learned that the Israeli army bombed a house in Beit Lahiya in the northern Gaza on the early morning of the 11th local time, killing 18 people and leaving many others missing. (CCTV News)The CSI A500ETF paid dividends for the first time. On December 11th, ICBC Credit Suisse announced the dividend, becoming the first CSI A500ETF product to announce the dividend. The dividend plan is to allocate 0.066 yuan for every 10 fund shares, the base date of income distribution is November 29, and the net value of fund shares on the base date is 1.0078 yuan. In addition, ICBC Credit Suisse CSI A500ETF's dividend registration date is December 13th, and the cash dividend payment date is December 18th.Yongtai Bio-product, a new open-source shareholding company, was recognized by CDE for breakthrough therapy. On December 11th, official website, China National Medical Products Administration Drug Evaluation Center (CDE), recently announced that the anti-CD19 single-chain antibody chimeric antigen receptor T cell injection (CAR-T-19 cell injection for short) developed by Yongtai Bio-B (06978.HK) was successfully included in the list of breakthrough therapy varieties by CDE, and the indication was recurrence under 25 years old/.